The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Align Technology Inc

Nasdaq: ALGN
Last

(U.S.) $65.87

Today's change-1.51 -2.24%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.
 

Align Technology Inc

Nasdaq: ALGN
Last

(U.S.) $65.87

Today's change-1.51 -2.24%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Align Technology Inc down (U.S.)$1.51

Align Technology Inc closed sharply lower Friday, dropping (U.S.)$1.51 or 2.24% to (U.S.)$65.87. Shares have lost 0.41% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 28.61% during the last year.

Key company metrics

  • Open(U.S.) $67.10
  • Previous close(U.S.) $67.38
  • High(U.S.) $67.34
  • Low(U.S.) $65.02
  • Bid / Ask-- / --
  • YTD % change+0.030%
  • Volume558,528
  • Average volume (10-day)783,452
  • Average volume (1-month)627,984
  • Average volume (3-month)673,294
  • 52-week range(U.S.) $51.65 to (U.S.) $69.36
  • Beta2.05
  • Trailing P/E37.20×
  • P/E 1 year forward31.49×
  • Forward PEG1.60×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.77
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+17.03%

Based on its net profit margin of 17.03%, Align Technology Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue230208209198
Total other revenue--------
Total revenue230208209198
Gross profit173158159151
Total cost of revenue57505147
Total operating expense171170167149
Selling / general / administrative10010210188
Research & development14181614
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income59384249
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax60364247
Income after tax49283136
Income tax, total1191111
Net income49283136
Total adjustments to net income--------
Net income before extra. items49283136
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items49283136
Inc. avail. to common incl. extra. items49283136
Diluted net income49283136
Dilution adjustment----00
Diluted weighted average shares81818182
Diluted EPS excluding extraordinary itemsvalue per share0.600.340.390.44
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.600.340.390.44